We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

43 hedge funds and large institutions have $90.4M invested in Global Cord Blood Corporation in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 5

30% more funds holding

Funds holding: 3343 (+10)

2% more capital invested

Capital invested by funds: $88.7M → $90.4M (+$1.74M)

5.17% less ownership

Funds ownership: 18.24%13.06% (-5.2%)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
43
Holders Change
+10
Holders Change %
+30.3%
% of All Funds
1.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
7
Reduced
8
Closed
5
Calls
Puts
Net Calls
Net Calls Change

CO Hedge Fund Activity: Q2 2017 in Review

43 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2017, worth a combined $90.4M — up 2% from $88.7M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CO positions and 5 closed out — a net gain of 10 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $2.33M. The largest seller was Skandinaviska Enskilda Banken (SEB), cutting an estimated $31M.

  • 43 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2017, up from 33 in Q1 2017.
  • Funds reported $90.4M of Global Cord Blood Corporation stock for Q2 2017, up 2% quarter-over-quarter.
  • 15 funds opened new Global Cord Blood Corporation positions in Q2 2017 and 5 closed out, a net change of +10 holders.
  • The largest Global Cord Blood Corporation buyer in Q2 2017 was Renaissance Technologies, an estimated $2.33M added.
  • The largest Global Cord Blood Corporation seller in Q2 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $31M sold.

Based on aggregated 13F filings for Q2 2017.